1974
DOI: 10.1136/bmj.3.5924.171
|View full text |Cite
|
Sign up to set email alerts
|

Letter: Effect of natural oestrogens on coagulation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
1

Year Published

1978
1978
2006
2006

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 1 publication
0
5
1
Order By: Relevance
“…Through its ability to alter megakaryocytic differentiation and proplatelet formation it is possible that oestrogen could modify the number of platelets available to form thrombi in this mouse model. However, while oestrogen treatment in humans has been shown to alter platelet number [8,9] other studies have failed to note any change [19]. These discrepancies coupled with differences in the routes of administration make the relevance of our results to the clinical setting unclear.…”
Section: Discussioncontrasting
confidence: 74%
See 1 more Smart Citation
“…Through its ability to alter megakaryocytic differentiation and proplatelet formation it is possible that oestrogen could modify the number of platelets available to form thrombi in this mouse model. However, while oestrogen treatment in humans has been shown to alter platelet number [8,9] other studies have failed to note any change [19]. These discrepancies coupled with differences in the routes of administration make the relevance of our results to the clinical setting unclear.…”
Section: Discussioncontrasting
confidence: 74%
“…Similarly, human studies have not published data relating 0167 oestrogen treatment to changes in MK and platelet number 8,9. Therefore, we examined the effect of smaller supraphysiological doses of 17-h oestradiol and circulating oestrogen concentrations on megakaryocytopoesis and related this to circulating platelet numbers in mice in vivo.…”
Section: Introductionmentioning
confidence: 96%
“…1954, Pechet and Alexander 1961, Talbert and Langdale 1964, and plasminogen levels (Bonnaret a!. 1970) and it is reported to reduce levels of antithrombin III (Notelovitz andGreig 1976, Peterson eta!. 1970).…”
Section: Resultsmentioning
confidence: 99%
“…We also identified a controversial reduction of plasma fibrinogen after menopause. Investigators have long been trying to establish whether estrogen replacement therapy results in increased fibrinogen concentration [53], but no consensus has been reached [54].…”
Section: Discussionmentioning
confidence: 99%